60 related articles for article (PubMed ID: 195363)
1. Enhancement of platelet sensitivity to ADP-aggregation by isometric exercise in arteriosclerosis patients and its prevention.
Sano T; Motomiya T; Yamazaki H; Shimamoto T
Thromb Haemost; 1977 Apr; 37(2):329-38. PubMed ID: 195363
[TBL] [Abstract][Full Text] [Related]
2. Proceedings: Enhancement of ADP-induced platelet aggregation by isometric hand-grip excercise in sclerotic patients and its prevention by EG-626, cAMPPDE inhibitor.
Sano T; Motimiya T; Yamazaki H; Shinamoto T
Thromb Diath Haemorrh; 1975 Sep; 34(1):344. PubMed ID: 171796
[No Abstract] [Full Text] [Related]
3. Platelet aggregation and cyclic nucleotide phosphodiesterase activity in arteriosclerotic patients.
Yamazaki H; Motomiya T; Mashimo N; Asano T; Hidaka H
Thromb Haemost; 1978 Feb; 39(1):158-66. PubMed ID: 205971
[TBL] [Abstract][Full Text] [Related]
4. Platelet release reaction in vivo in patients with ischaemic heart disease after isometric exercise and its prevention with dipyridamole.
Sano T; Motomiya T; Yamazaki H
Thromb Haemost; 1980 Feb; 42(5):1589-97. PubMed ID: 6966082
[TBL] [Abstract][Full Text] [Related]
5. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
Lam SC; Guccione MA; Packham MA; Mustard JF
Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
[TBL] [Abstract][Full Text] [Related]
6. Phase analysis of platelet aggregation in acute disturbances of cerebral circulation.
Petrova TR; Pavlishchuk SA; Grigoriev GI
Cor Vasa; 1975; 17(2):102-11. PubMed ID: 1157498
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
8. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
9. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregability in cardiac syndrome X.
Lanza GA; Andreotti F; Sestito A; Sciahbasi A; Crea F; Maseri A
Eur Heart J; 2001 Oct; 22(20):1924-30. PubMed ID: 11601836
[TBL] [Abstract][Full Text] [Related]
11. Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method.
Sudo T; Ito H; Kimura Y
Platelets; 2003 Jun; 14(4):239-46. PubMed ID: 12850833
[TBL] [Abstract][Full Text] [Related]
12. [ADP-induced platelet aggregation in vascular diseases of the elderly].
Pernigotti L; Molaschi M; Macchione C; Ferrario E; Poli L
Minerva Med; 1981 Oct; 72(39):2617-20. PubMed ID: 7290465
[TBL] [Abstract][Full Text] [Related]
13. [Platelet function, hypertension and ischemic heart disease].
Nyrop M
Ugeskr Laeger; 1989 Sep; 151(39):2504-7. PubMed ID: 2678654
[TBL] [Abstract][Full Text] [Related]
14. [Influence of acute exertion and physical training on platelet function of the coronary patient].
Broustet JP; Boisseau M; Bouloumie J; Emeriau JP; Bricaud H
Arch Mal Coeur Vaiss; 1976 Mar; 69(3):305-13. PubMed ID: 828016
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of platelet function using stagnation point flow aggregometry. First clinical results.
Reininger CB; Reininger AJ; Hörmann A; Steckmeier B; Schweiberer L
Int Angiol; 1992; 11(4):247-55. PubMed ID: 1295930
[TBL] [Abstract][Full Text] [Related]
16. Optimizing platelet P2Y12 inhibition for patients undergoing PCI.
Steinhubl S; Roe MT
Cardiovasc Drug Rev; 2007; 25(2):188-203. PubMed ID: 17614940
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).
Dyszkiewicz-Korpanty A; Olteanu H; Frenkel EP; Sarode R
Platelets; 2007 Nov; 18(7):491-6. PubMed ID: 17852774
[TBL] [Abstract][Full Text] [Related]
18. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
[TBL] [Abstract][Full Text] [Related]
19. Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.
Fontana P; Dupont A; Gandrille S; Bachelot-Loza C; Reny JL; Aiach M; Gaussem P
Circulation; 2003 Aug; 108(8):989-95. PubMed ID: 12912815
[TBL] [Abstract][Full Text] [Related]
20. [A novel whole blood aggregometer].
Konishi R; Seo N
Masui; 2003 Jan; 52(1):78-83. PubMed ID: 12632629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
